Additionally, in The Cancer Genome Atlas (TCGA) database, we observed that lower DPP4 expression levels were correlated with higher Gleason scores, advanced cT and pathological stages, tumour metastasis, and shorter progression‐free survival rates in PCa patients. The gene discussed is DPP4; the disease is posterior cortical atrophy.